Evidence map›Paper›PMID 38046633›Full record

ArticleRSC advances2023

Experimental and

Ansa Latif, Muhammad Mohsin, Ijaz Ahmad Bhatti, Asif Ali Tahir, Muhammad Tahir Hussain, Javed Iqbal

Abstract read
In one paragraph

Article in RSC advances, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Ansa LatifDepartment of Chemistry, University of Agriculture Faisalabad Pakistan ijazchem@yahoo.com m.mohsin618@gmail.com.
Muhammad MohsinDepartment of Chemistry, University of Agriculture Faisalabad Pakistan ijazchem@yahoo.com m.mohsin618@gmail.com.ORCID https://orcid.org/0000-0001-7101-6323
Ijaz Ahmad BhattiDepartment of Chemistry, University of Agriculture Faisalabad Pakistan ijazchem@yahoo.com m.mohsin618@gmail.com.
Asif Ali TahirSolar Energy Research Group, Environment and Sustainability Institute, Department of Engineering, Faculty of Environment, Science and Economy, University of Exeter Penryn Campus Cornwall TR10 9FE UK.ORCID https://orcid.org/0000-0003-1985-6127
Muhammad Tahir HussainDepartment of Applied Sciences, National Textile University Faisalabad 37610 Pakistan.
Javed IqbalDepartment of Chemistry, University of Agriculture Faisalabad Pakistan ijazchem@yahoo.com m.mohsin618@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pristine ZnO and Co-doped ZnO photocatalyst thin films were fabricated on a ceramic substrate by spray pyrolysis. The optical, morphological and structural properties of the fabricated nanophotocatalyst thin films were analyzed using X-ray diffraction (XRD), scanning electron microscopy (SEM), energy-dispersive X-ray (EDX) spectroscopy and Fourier transform infrared (FTIR) spectroscopy. Operational parameters, including dye concentration, oxidant concentration, irradiation time and pH for dye degradation, were optimized by response surface methodology (RSM). The maximum degradation obtained was 93% under ideal conditions, such as pH 7, 3 h of direct sunlight irradiation, 30 mM concentration of oxidant and 10 ppm concentration of dye (MB). The evaluation of the extent of degradation was done using the UV/visible spectrophotometry technique. The reusability of the fabricated thin film was examined under optimized conditions. Density functional theory (DFT) with the B3LYP/LanL2DZ method was used for the theoretical modelling of the fabricated nanomaterials. The optimized structure, theoretical band gaps, IR spectra and Raman spectra of the fabricated pristine ZnO and Co:ZnO nanophotocatalysts were determined.

Identifiers

PMID38046633
PMCPMC10690497

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.